Campingcar Besinov UBS AG THE WORLD WIDE OFFSHORE SCANDAL
WELCOME IN MY POTAL

Campingcar Besinov UBS AG THE WORLD WIDE OFFSHORE SCANDAL

THE SWISS CRIMES BEHIND THE NEUTRAL FACADE & THE CRIMES WITH THE GLOBAL RESOURCES
 
RegisterEventsSearchPublicationsPICS & CONTACTCalendarHomeLog inFAQGallery

Share
 

 Interview with Dr. Christian Wildmoser, Partner at CVC Capital Partners Dr. Christian Wildmoser Partner

Go down 
AuthorMessage
Admin
Admin
Admin
Admin

Female
Number of posts : 6344
Birthday : 1952-04-20
Age : 67
Reputation : 0
Points : 20749
Registration date : 2007-04-25

Interview with Dr. Christian Wildmoser, Partner at CVC Capital Partners Dr. Christian Wildmoser Partner Empty
PostSubject: Interview with Dr. Christian Wildmoser, Partner at CVC Capital Partners Dr. Christian Wildmoser Partner   Interview with Dr. Christian Wildmoser, Partner at CVC Capital Partners Dr. Christian Wildmoser Partner I_icon_minitimeMon Jul 01, 2019 6:30 pm

Interview with Dr. Christian Wildmoser, Partner at CVC Capital Partners Dr. Christian Wildmoser Partner, CVC Capital Partners Dr. Christian Wildmoser is a partner at CVC Capital Partners and is involved in CVC’s global activities in the chemicals sector. He focuses on private equity activities in Germany, Austria and Switzerland. Dr. Wildmoser joined CVC Capital Partners in 2000 as Senior Managing Director and was promoted to Partner in 2008. Since 2008, he had been a member of the Supervisory Board of Evonik Industries AG, from which he resigned effectively during Evonik’s annual shareholder’s meeting on May 18, 2016. Before joining CVC, Dr. Wildmoser served as Chief Executive Officer at Helarb Management. Dr. Wildmoser studied economics and received his Ph.D. from the University of Vienna, Austria. 
CVC Capital Partners is a leading private equity and investment advisory firm with offices in Europe, Asia and the US. CVC manages capital on behalf of over 300 institutional, governmental and private investors worldwide. Since its inception, CVC has secured commitments of more than USD 71bn in funds. CVC’s major investment focus lies in global industrial and service businesses. The target minimum equity investment is USD 150m for its European funds and USD 50m for its Asian funds. Its current portfolio includes over 45 investments from a variety of sectors, including stakes in major chemicals companies, such as Evonik and Univar. In 2015, the M&A trends in the European chemicals industry were driven by an increased focus on portfolio realignments – to shift from lower-value commodity upstream businesses towards more specialtydownstream sectors. How do you see these trends influencing the M&A dynamics in the European chemicals market and what additional trends do you expect going forward? I expect the high M&A activity in the specialty chemicals sector to continue. These companies are especially appealing compared to commodity-focused businesses. The current market environment, with historically low oil prices, hampers penetration of, and revenue generation from, petroleum-based commodities. In addition, the chemicals industry appears to be under pressure when considering recent share price developments, since it is a competitive industry with high operating leverage. Lanxess, Evonik and BASF are trading below their share prices from one year ago. Hence, portfolio improvements will remain a major topic for future development. The joint venture initiated by Saudi Aramco and Lanxess is a good example of an upstream player attempting to expand downstream the value chain. I expect these realignments to continue in the future. A similar strategic pattern seems to apply to the Dow Chemical – DuPont deal. Yes, exactly and this transaction serves as a good example to demonstrate several topics. Conglomerates were on both ends of the transaction. At the time of the deal announcement, DuPont was already in the process of focusing on its agricultural, nutrition and high-end specialty business through various transactions, such as the Chemours spin-off. Subsequent to the commodity spin-off, DuPont made significant progress. On the contrary, after Dow Chemical acquired Rohm and Haas, market circumstances did not allow it to exit its commodity business entirely. Market conditions changed and commodity prices, such as ethylene, recovered. In retrospect, it was a solid decision of Dow Chemical to hold on to its commodity business. Nevertheless, Dow Chemical made only minimal progress towards focusing on specialty chemicals. As a result, the deal between Dow Chemical and DuPont may create value for both by creating three highly focused leading companies with critical scale in agriculture, material science and specialty products.
Back to top Go down
View user profile http://www.campingcarbesinov.com
 
Interview with Dr. Christian Wildmoser, Partner at CVC Capital Partners Dr. Christian Wildmoser Partner
Back to top 
Page 1 of 1

Permissions in this forum:You cannot reply to topics in this forum
Campingcar Besinov UBS AG THE WORLD WIDE OFFSHORE SCANDAL :: BANK UBS / SOCIETE GENERAL PRIVAT BANKING (Suisse) S.A. CZECH REPUBLIC/RUSSIA-
Jump to: